We should start by acknowledging that the debate we face is not lives versus the economy; it is lives versus lives. Not only has the lockdown created a backlog of people awaiting other healthcare; it will mean greater shortages of healthcare in the future. Just last week, Pharmac froze its plans to fund Keytruda because it was concerned about cost. The ability to afford warm, dry homes for many people has just been set back years, and that has health implications too. And then, most sadly, there are the costs of domestic violence, depression, and anxiety throughout this period and to come, which can cost lives too. I'm sorry to say that to the best of my knowledge, this Government has made no attempt to quantify those costs that is remotely comparable with the enthusiasm it has shown for modelling and pointing to the risks of the virus. We shouldn't be paralysed by fear of the one thing while ignoring those other dangers; we need to balance them both.